The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

Aug. 21, 2018
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Jane B. Neckers, Bethesda, MD (US);

Yeong Sang Kim, Gaithersburg, MD (US);

Sunmin Lee, Boyds, MD (US);

Vineet Kumar, Frederick, MD (US);

Sanjay V. Malhotra, Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 49/796 (2006.01); C07C 255/56 (2006.01); C07C 205/45 (2006.01); A61K 31/12 (2006.01); A61K 31/275 (2006.01); C07C 49/813 (2006.01); C07C 49/84 (2006.01); C07C 49/80 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07C 49/796 (2013.01); A61K 31/12 (2013.01); A61K 31/275 (2013.01); A61K 45/06 (2013.01); C07C 49/80 (2013.01); C07C 49/813 (2013.01); C07C 49/84 (2013.01); C07C 205/45 (2013.01); C07C 255/56 (2013.01);
Abstract

Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein Rto Rand Xto Xare as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.


Find Patent Forward Citations

Loading…